Original Literature | Model OverView |
---|---|
Publication
Title
Glucocorticoids and the innate immune system: crosstalk with the toll-likereceptor signaling network.
Affiliation
Hospital for Special Surgery, Department of Microbiology & Immunology, WeillMedical College of Cornell University, 535 E70th Street, Research Building Room425, New York, NY 10021,USA.
Abstract
Toll-like receptors (TLRs) are responsible for the recognition of a variety ofmicrobial pathogens and the initial induction of immune and inflammatoryresponses. These responses are normally restricted by the adrenally producedglucocorticoid hormones which provide a feedback mechanism to curb unabatedinflammation. Glucocorticoids act through a ligand-dependent transcriptionfactor-the glucocorticoid receptor (GR), which engages in a complex network ofprotein:protein and protein:DNA interactions ultimately activating or repressingtarget gene transcription. Not surprisingly, multiple mechanisms account for theglucocorticoid interference with TLR signaling including enhanced expression ofthe natural inhibitors of TLR pathways, direct repression of TLR-activatedtranscriptional regulators and cross-utilization of cofactors essential for bothGR and TLR signaling. Here we discuss recent and unexpected examples ofcrosstalk between the two transcriptional networks and the emerging role of GRin the regulation of innate immunity.
PMID
17576036
|
Entity
Process
pro-opiomelanocortin
--
G010266
cso30:c:mRNA
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m93252
10
infinite
0
TRANSFAC | G010266 |
--
tyrosine hydroxylase
--
G010592
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m93546
10
infinite
0
TRANSFAC | G010592 |
--
Raf-1
--
MO000000015
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m101
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000015 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16
10
infinite
0
TRANSPATH | MO000000058 |
--
IkappaB:NF-kappaB
--
MO000000215
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m186
10
infinite
0
TRANSPATH | MO000000215 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
SOCS/CIS family
--
MO000017115
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2002
10
infinite
0
TRANSPATH | MO000017115 |
--
glucocorticoids
--
MO000021732
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6069
10
infinite
0
TRANSPATH | MO000021732 |
--
MKK4{p}
--
MO000038341
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16555
10
infinite
0
TRANSPATH | MO000038341 |
--
MKK6{p}
--
MO000038355
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16567
10
infinite
0
TRANSPATH | MO000038355 |
--
Raf-1{p}
--
MO000038411
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16621
10
infinite
0
TRANSPATH | MO000038411 |
--
p160
--
MO000038964
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17147
10
infinite
0
TRANSPATH | MO000038964 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
osteocalcin
--
MO000066783
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m41640
10
infinite
0
TRANSPATH | MO000066783 |
--
GRIP1
--
MO000074564
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m49366
10
infinite
0
TRANSPATH | MO000074564 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
GILZ: Jun
--
e100
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m105
0
infinite
0
--
GILZ: GILZ
--
e101
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m107
0
infinite
0
--
TLR2 ligand
--
e103
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m109
0
infinite
0
--
TLR2 ligand: TLR2
--
e104
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m110
0
infinite
0
--
csml-variable:Double
m111
10
infinite
0
Affymetrix | 1369_s_at |
Ensembl | ENSG00000169429 |
HGNC | IL8 |
OMIM | 146930 |
Proteome | HumanPSD/IL8 |
RefSeq | NM_000584 |
TRANSFAC | G000317 |
Unigene | Hs.551925 |
--
TNF-alpha receptor
--
e106
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m112
0
infinite
0
--
TNF-alpha: TNF-alpha receptor
--
e107
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m113
0
infinite
0
--
IFN-gamma receptor
--
e108
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m114
0
infinite
0
--
IFN-gamma: IFN-gamma receptor
--
e109
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m115
0
infinite
0
--
GR: Hsp90: Hsp70
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
IRF-1 {p} {nucleus}
--
e110
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m116
0
infinite
0
--
p300:CBP
--
e111
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m117
0
infinite
0
--
p300: CBP: IRF3 {p} : IRF3
--
e112
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m118
0
infinite
0
--
GRIP1: IRF3 {p} : IRF3
--
e113
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m119
0
infinite
0
--
csml-variable:Double
m120
10
infinite
0
Affymetrix | 1418930_at |
Ensembl | ENSMUSG00000034855 |
MGD | Cxcl10 |
Proteome | HumanPSD/Cxcl10 |
RefSeq | NM_021274 |
TRANSFAC | G001062 |
Unigene | Mm.263514 |
--
p300:CBP: GRIP1
--
e115
cso30:c:Complex
cso30:i:CC_Nucleolus
--
--
csml-variable:Double
m121
0
infinite
0
--
IRF-1 {p}
--
e116
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m122
0
infinite
0
--
casein kinase II
--
e117
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m123
0
infinite
0
--
IRF3 {p} : IRF3: NF-kappaB
--
e118
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m124
0
infinite
0
--
IRF-7 {activated}
--
e119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m125
10
infinite
0
TRANSPATH | MO000007702 |
--
glucocorticoids: GR: Hsp90: Hsp70
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
IRF-7 {nucleus}}
--
e120
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m126
10
infinite
0
TRANSPATH | MO000007702 |
--
p300: CBP: IRF-7{nucleus}
--
e121
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m127
0
infinite
0
--
csml-variable:Double
m128
0
infinite
0
--
p300:CBP: IRF-1{p} {nucleus}
--
e123
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m129
0
infinite
0
--
csml-variable:Double
m130
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
simple GRE
--
e14
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m14
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: simple GRE
--
e15
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m15
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: NF-kappaB
--
e16
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: STAT5
--
e17
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m18
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: STAT3
--
e18
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: AF-2
--
e20
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m21
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: SRC-1
--
e21
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m22
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: GRIP1
--
e22
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m23
0
infinite
0
--
glucocorticoids: GR: Hsp90: Hsp70 {nucleus}: SRC-3
--
e23
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m24
0
infinite
0
--
csml-variable:Double
m25
10
infinite
0
Affymetrix | 207700_s_at |
Ensembl | ENSG00000124151 |
HGNC | NCOA3 |
OMIM | 601937 |
Proteome | HumanPSD/NCOA3 |
RefSeq | NM_006534 |
TRANSPATH | MO000088113 |
Unigene | Hs.592142 |
UniProt | Q9Y6Q9-2 |
--
csml-variable:Double
m26
0
infinite
0
--
csml-variable:Double
m27
0
infinite
0
--
csml-variable:Double
m28
0
infinite
0
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
csml-variable:Double
m31
0
infinite
0
--
csml-variable:Double
m32
0
infinite
0
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
0
infinite
0
--
csml-variable:Double
m37
0
infinite
0
--
csml-variable:Double
m38
0
infinite
0
--
csml-variable:Double
m39
0
infinite
0
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
pCAF
--
e40
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m41
0
infinite
0
--
CRAM1
--
e41
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m42
0
infinite
0
--
csml-variable:Double
m43
10
infinite
0
Affymetrix | 104591_g_at |
Ensembl | ENSMUSG00000005583 |
MGD | 5430401D19Rik |
Proteome | HumanPSD/Mef2c |
RefSeq | NM_025282 |
TRANSFAC | T09547 |
TRANSPATH | MO000056814 |
Unigene | Mm.207461 |
UniProt | Q8CFN5 |
--
csml-variable:Double
m44
0
infinite
0
--
csml-variable:Double
m45
0
infinite
0
--
TLR ligand
--
e46
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m47
0
infinite
0
--
TLR ligand : TLR
--
e47
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m48
0
infinite
0
--
TLR ligand : TLR: TLR
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m49
0
infinite
0
--
TLR ligand : TLR: TLR: TIRAP: MyD88
--
e49
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m63
0
infinite
0
--
GILZ
--
e5
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m5
10
infinite
0
Affymetrix | 207001_x_at |
Ensembl | ENSG00000157514 |
HGNC | TSC22D3 |
OMIM | 300506 |
Proteome | HumanPSD/TSC22D3 |
RefSeq | NM_001015881 |
TRANSPATH | MO000085795 |
Unigene | Hs.133473 |
UniProt | Q99576-1 |
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
GILZ: NF-kappaB
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
TLR ligand : TLR: TLR: TIRAP: MyD88: IRAK-4: IRAK1
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
TLR ligand : TLR: TLR: TIRAP: MyD88: IRAK-4: IRAK1 {p}
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m66
0
infinite
0
--
TLR ligand : TLR: TLR: TRIF: TRAM
--
e66
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m67
0
infinite
0
--
csml-variable:Double
m68
0
infinite
0
--
IRAK1 {p}: TRAF6
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IRAK1{p}: TRAF6 {p}: TAK1
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
IRAK1{p}: TRAF6 {p}: TAK1 {p}
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
csml-variable:Double
m73
0
infinite
0
--
csml-variable:Double
m74
0
infinite
0
--
csml-variable:Double
m76
0
infinite
0
--
csml-variable:Double
m78
0
infinite
0
--
IkappaB {p}:NF-kappaB
--
e76
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
IkappaB remnants
--
e77
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m80
0
infinite
0
--
NF-kappaB {cytoplasm}
--
e78
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m81
10
infinite
0
TRANSPATH | MO000000058 |
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
dsRNA:TLR3: TRIF
--
e80
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m83
0
infinite
0
--
dsRNA:TLR3: TRIF: IRF3: IKK-i: TBK1
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
IRF3 {p}
--
e82
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
dsRNA:TLR3: TRIF: IKK-i: TBK1
--
e83
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m86
0
infinite
0
--
IRF3 {p} : IRF3
--
e84
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
IRF3 {p} : IRF3
--
e85
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
dsRNA:TLR3: TRIF: RIP1
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
MKP
--
e87
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m91
10
infinite
0
InterPro | IPR000340 |
TRANSPATH | MO000016814 |
--
TIRAp ramnents
--
e88
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m92
0
infinite
0
--
TIRAP {ub}
--
e89
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
SOCS/CIS family: Jak
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m95
0
infinite
0
--
STATs {cytoplasm}: Jak
--
e93
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m97
0
infinite
0
--
csml-variable:Double
m98
0
infinite
0
--
Jak remnants
--
e95
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m99
0
infinite
0
--
GILZ: Raf-1
--
e96
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m100
0
infinite
0
--
ERK1 {activated}
--
e98
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m103
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000004670 |
--
GILZ: Fos
--
e99
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m104
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6069*m11*0.1
nodelay
--
0
PMID: 17576036, 10099820 In its inactive state, GR resides in the cytoplasm as a part of a large multiprotein complex containing heat shock proteins (hsp90, hsp70), co-chaperones and immunofillins. Ligand binding induces a series of conformational changes in the receptor that result in rearrangement of this complex, exposure of the GR nuclear localization signal and rapid nuclear translocation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m13*m1798*0.1
nodelay
--
0
PMID: 17576036, 2169352, 10995388, 9388192 Tethering GREs do not contain bona fide DNA recognition sequence for GR, but rather a binding site for another transcription factor which recruits GR through protein:protein interactions. Binding to tethering GREs often requires neither GR DNA binding activity nor its dimerization. Several transcription factors, including AP1, NFkappaB, Stat3 and Stat5 can provide a ¡Ètether¡É for GR.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c284 : 1
stoichiometry:c285 : 1
stoichiometry:c286 : 1
m88*m117*0.1
nodelay
--
0
PMID: 17576036, 16932750 This phosphorylation is required for nuclear translocation of IRF3 as well as binding of CBP/p300, the best known IRF3 coactivators.
p101
p101
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c287 : 1
stoichiometry:c288 : 1
stoichiometry:c291 : 1
stoichiometry:c289 : 1
m49366*m88*0.1
nodelay
--
0
PMID: 17576036 GR and IRF3 hinder each other's binding to GRIP1 in vitro suggesting that interacting surfaces may partially overlap precluding GR and IRF3 from binding GRIP1 at the same time. PMID: 17576036 both GRIP1 and IRF3 are conventional interacting partners for CBP/p300, their interaction with each other is CBP-independent.
p102
p102
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c293 : 1
stoichiometry:c296 : 1
stoichiometry:c292 : 1
m118*0.1
nodelay
--
0
PMID: 17576036 glucocorticoids strongly inhibited dsRNA-induced expression of multiple cytokines and chemokines including interferon beta, IP10 and RANTES, known transcriptional targets of IRF3.
p103
p103
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c294 : 1
stoichiometry:c297 : 1
stoichiometry:c299 : 1
m118*0.1
nodelay
--
0
PMID: 17576036 glucocorticoids strongly inhibited dsRNA-induced expression of multiple cytokines and chemokines including interferon beta, IP10 and RANTES, known transcriptional targets of IRF3.
p104
p104
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c295 : 1
stoichiometry:c298 : 1
stoichiometry:c300 : 1
m118*0.1
nodelay
--
0
PMID: 17576036 glucocorticoids strongly inhibited dsRNA-induced expression of multiple cytokines and chemokines including interferon beta, IP10 and RANTES, known transcriptional targets of IRF3.
p105
p105
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c301 : 1
stoichiometry:c302 : 1
stoichiometry:c303 : 1
m49366*m117*0.1
nodelay
--
0
PMID: 17576036 both GRIP1 and IRF3 are conventional interacting partners for CBP/p300, their interaction with each other is CBP-independent.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c304 : 1
stoichiometry:c305 : 1
m977*0.1
nodelay
--
0
PMID: 17576036 TLR4 is the main LPS sensor that can activate IRF3 through both MyD88- and TRIF-dependent pathways.
p107
p107
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c306 : 1
stoichiometry:c307 : 1
stoichiometry:c308 : 1
m970*m123*0.1
nodelay
--
0
PMID: 17576036, 10094406 casein kinase II-dependent phosphorylation of IRF1 is required for its full transactivation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c310 : 1
stoichiometry:c311 : 1
stoichiometry:c312 : 1
m88*m16*0.1
nodelay
--
0
PMID: 17576036, 16143103 because both GR and IRF3 appear to interact with the Rel domain of p65, IRF3 and GR were proposed to compete for the same binding site on NFkappaB.
p109
p109
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c313 : 1
stoichiometry:c315 : 1
stoichiometry:c314 : 1
m980*m68*0.1
nodelay
--
0
PMID: 17576036, 11468175 IRAK4/1 initiate signaling cascades that lead to the activation of NFkappaB, AP1 and possibly IRF7 and IRF5.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m13*m1360*0.1
nodelay
--
0
PMID: 17576036, 2169352, 10995388, 9388192 Tethering GREs do not contain bona fide DNA recognition sequence for GR, but rather a binding site for another transcription factor which recruits GR through protein:protein interactions. Binding to tethering GREs often requires neither GR DNA binding activity nor its dimerization. Several transcription factors, including AP1, NFkappaB, Stat3 and Stat5 can provide a ¡Ètether¡É for GR.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c317 : 1
stoichiometry:c318 : 1
m125*0.1
nodelay
--
0
PMID: 17576036 Several IRFs, including IRF1, 2, 3, 5 and 7 interact with CBP/p300 coactivators through the C-terminal IAD domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c321 : 1
stoichiometry:c323 : 1
stoichiometry:c327 : 1
m117*m126*0.1
nodelay
--
0
PMID: 17576036 Several IRFs, including IRF1, 2, 3, 5 and 7 interact with CBP/p300 coactivators through the C-terminal IAD domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c322 : 1
stoichiometry:c325 : 1
stoichiometry:c329 : 1
m117*m116*0.1
nodelay
--
0
PMID: 17576036 Several IRFs, including IRF1, 2, 3, 5 and 7 interact with CBP/p300 coactivators through the C-terminal IAD domain.
p113
p113
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c319 : 1
stoichiometry:c324 : 1
stoichiometry:c328 : 1
m117*m974*0.1
nodelay
--
0
PMID: 17576036 Several IRFs, including IRF1, 2, 3, 5 and 7 interact with CBP/p300 coactivators through the C-terminal IAD domain.
p114
p114
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c320 : 1
stoichiometry:c326 : 1
stoichiometry:c330 : 1
m117*m979*0.1
nodelay
--
0
PMID: 17576036 Several IRFs, including IRF1, 2, 3, 5 and 7 interact with CBP/p300 coactivators through the C-terminal IAD domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c331 : 1
stoichiometry:c332 : 1
m81*0.1
nodelay
--
0
--
p71
p116
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c333 : 1
stoichiometry:c335 : 1
stoichiometry:c334 : 1
m13*0.1
nodelay
--
0
PMID: 17576036, 11468175, 9430225, 17208592 Glucocorticoid-inducible leucine zipper (GILZ) is a small protein with a wide spectrum of anti-inflammatory activities including inhibition of LPS-induced expression of TLR2 in macrophages and of TLR 2- and 3-mediated NFkappaB activation in airway epithelial cells; inhibition of dendritic cells¡Ç maturation, and enhancement of spontaneous thymocyte apoptosis, likely through downregulation of the anti-apoptotic factor Bcl-X. PMID: 17576036 In HeLa cervical carcinoma cells, the basal TLR2 expression is low but is induced upon exposure to lipoprotein from the Gram-negative bacterium Haemophilus influenzae and further potentiated by glucocorticoids. PMID: 17576036,16765091 in dendritic cells, glucocorticoids augment the expression of both TLR2 and TLR4, but inhibit the production of proinflammatory cytokines TNF-alpha and IL-12 in response to TLR agonists, suggesting that TLR2 signaling is blocked downstream of the receptor and that a mere increase in the amount of TLR2 does not relieve this block.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c336 : 1
stoichiometry:c256 : 1
m108*0.1
nodelay
--
0
PMID: 17576036, 11468175, 9430225, 17208592 Glucocorticoid-inducible leucine zipper (GILZ) is a small protein with a wide spectrum of anti-inflammatory activities including inhibition of LPS-induced expression of TLR2 in macrophages and of TLR 2- and 3-mediated NFkappaB activation in airway epithelial cells; inhibition of dendritic cells¡Ç maturation, and enhancement of spontaneous thymocyte apoptosis, likely through downregulation of the anti-apoptotic factor Bcl-X.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m13*m20*0.1
nodelay
--
0
PMID: 17576036, 16751179, 15957004, 12215713 the best understood interaction is that between the GR AF2 and the p160 family members: SRC1, SRC2/GRIP1/TIF2 and SRC3/AIB1/ACTR/Rac3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m13*m12297*0.1
nodelay
--
0
PMID: 17576036, 16751179, 15957004, 12215713 the best understood interaction is that between the GR AF2 and the p160 family members: SRC1, SRC2/GRIP1/TIF2 and SRC3/AIB1/ACTR/Rac3.
p14
p14
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c290 : 1
stoichiometry:c38 : 1
m13*m49366*0.1
nodelay
--
0
PMID: 17576036, 16751179, 15957004, 12215713 the best understood interaction is that between the GR AF2 and the p160 family members: SRC1, SRC2/GRIP1/TIF2 and SRC3/AIB1/ACTR/Rac3. PMID: 17576036 GR and IRF3 hinder each other's binding to GRIP1 in vitro suggesting that interacting surfaces may partially overlap precluding GR and IRF3 from binding GRIP1 at the same time.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m13*m25*0.1
nodelay
--
0
PMID: 17576036, 16751179, 15957004, 12215713 the best understood interaction is that between the GR AF2 and the p160 family members: SRC1, SRC2/GRIP1/TIF2 and SRC3/AIB1/ACTR/Rac3.
p16
p16
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c50 : 1
m631*m17147*0.1
nodelay
--
0
PMID: 17576036, 14966289, 14690606, 15988012 Although no DNA binding activity has been reported for p160 cofactors, bHLH/PAS domain reportedly binds several secondary coactivators such as flightless I, CoCoA, GAC63 and a component of SWI/SNF chromatin remodeling complex, BAF57.
p17
p17
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c51 : 1
m37680*m17147*0.1
nodelay
--
0
PMID: 17576036, 14966289, 14690606, 15988012 Although no DNA binding activity has been reported for p160 cofactors, bHLH/PAS domain reportedly binds several secondary coactivators such as flightless I, CoCoA, GAC63 and a component of SWI/SNF chromatin remodeling complex, BAF57.
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c52 : 1
m60467*m17147*0.1
nodelay
--
0
PMID: 17576036, 14966289, 14690606, 15988012 Although no DNA binding activity has been reported for p160 cofactors, bHLH/PAS domain reportedly binds several secondary coactivators such as flightless I, CoCoA, GAC63 and a component of SWI/SNF chromatin remodeling complex, BAF57.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c53 : 1
m54408*m17147*0.1
nodelay
--
0
PMID: 17576036, 14966289, 14690606, 15988012 Although no DNA binding activity has been reported for p160 cofactors, bHLH/PAS domain reportedly binds several secondary coactivators such as flightless I, CoCoA, GAC63 and a component of SWI/SNF chromatin remodeling complex, BAF57.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m12*0.1
nodelay
--
0
PMID: 17576036, 10099820 In its inactive state, GR resides in the cytoplasm as a part of a large multiprotein complex containing heat shock proteins (hsp90, hsp70), co-chaperones and immunofillins. Ligand binding induces a series of conformational changes in the receptor that result in rearrangement of this complex, exposure of the GR nuclear localization signal and rapid nuclear translocation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c337 : 1
stoichiometry:c56 : 1
m17147*m117*0.1
nodelay
--
0
PMID: 17576036, 9430642, 11997499, 15731352 The C-terminal half of p160s houses activation domains (AD) 1 and 2 which recruit histone acetyl transferases (CBP/p300 and pCAF) and arginine methyl transferases (CARM1 and PRMT1), respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c73 : 1
stoichiometry:c57 : 1
m17147*m41*0.1
nodelay
--
0
PMID: 17576036, 9430642, 11997499, 15731352 The C-terminal half of p160s houses activation domains (AD) 1 and 2 which recruit histone acetyl transferases (CBP/p300 and pCAF) and arginine methyl transferases (CARM1 and PRMT1), respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c74 : 1
stoichiometry:c58 : 1
m17147*m42*0.1
nodelay
--
0
PMID: 17576036, 9430642, 11997499, 15731352 The C-terminal half of p160s houses activation domains (AD) 1 and 2 which recruit histone acetyl transferases (CBP/p300 and pCAF) and arginine methyl transferases (CARM1 and PRMT1), respectively.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c76 : 1
stoichiometry:c59 : 1
m17147*m35749*0.1
nodelay
--
0
PMID: 17576036, 9430642, 11997499, 15731352 The C-terminal half of p160s houses activation domains (AD) 1 and 2 which recruit histone acetyl transferases (CBP/p300 and pCAF) and arginine methyl transferases (CARM1 and PRMT1), respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c77 : 1
stoichiometry:c60 : 1
m17147*m43*0.1
nodelay
--
0
p25
p25
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c78 : 1
stoichiometry:c61 : 1
m17147*m15404*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
p26
p26
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c79 : 1
stoichiometry:c62 : 1
m17147*m1320*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
p27
p27
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c82 : 1
stoichiometry:c63 : 1
m17147*m481*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
p28
p28
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c75 : 1
stoichiometry:c64 : 1
m17147*m16*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c83 : 1
stoichiometry:c81 : 1
m17147*m3431*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c8 : 1
m14*m13*0.1
nodelay
--
0
PMID: 17576036 Simple GREs contain a specific DNA sequence to which GR binds as a sole regulator, typically as a homodimer. PMID: 17576036, 17559307, 9582068 GREs have been proposed to serve as the second ¡Æallosteric ligand¡Ç for the receptor.
p30
p30
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m17147*m1633*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m17147*m46*0.1
nodelay
--
0
PMID: 17576036, 10817756, 15767262, 15169882 Historically identified as nuclear receptor coactivators, individual p160s are emerging as cofactors for a variety of non-receptor transcriptional regulators including MEF2C and myogenin, pRb, E2F1, MyoD, NFkappaB, STATs and most recently, IRFs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m47*m3962*0.1
nodelay
--
0
PMID: 17576036 Ligand-dependent homo- or heterodimerization of TLRs brings two TIR domains in close proximity allowing for the recruitment of additional adaptor molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m48*0.1
nodelay
--
0
PMID: 17576036 Ligand-dependent homo- or heterodimerization of TLRs brings two TIR domains in close proximity allowing for the recruitment of additional adaptor molecules.
p34
p34
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m1572*m6810*m49*0.1
nodelay
--
0
PMID: 17576036 Upon interaction with PAMPs, TLRs recruit adaptor proteins MyD88 and TRIF/TICAM1, which transmit signal to downstream kinases as well as ubuiquitin ligases involved in degradation of inhibitors of NFkappaB. PMID: 17576036 Two additional adaptor proteins, TIRAP and TRAM, likely facilitate the recruitment of MyD88 and TRIF to specific TLRs.
p35
p35
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c108 : 1
m49*m19005*m18998*0.1
nodelay
--
0
PMID: 17576036 Upon interaction with PAMPs, TLRs recruit adaptor proteins MyD88 and TRIF/TICAM1, which transmit signal to downstream kinases as well as ubuiquitin ligases involved in degradation of inhibitors of NFkappaB. PMID: 17576036 Two additional adaptor proteins, TIRAP and TRAM, likely facilitate the recruitment of MyD88 and TRIF to specific TLRs.
p36
p36
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m17258*m64*m63*0.1
nodelay
--
0
PMID: 17576036 MyD88 contains two protein:protein interaction domains: the C-terminal TIR domain interacts with TIR domain of TLRs and IL-1R, while the N-terminal death domain binds the death domain-containing protein kinases, such as the IL-1R-associated kinase 4 (IRAK4), which phosphorylate another kinase, IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
m65*0.1
nodelay
--
0
PMID: 17576036 MyD88 contains two protein:protein interaction domains: the C-terminal TIR domain interacts with TIR domain of TLRs and IL-1R, while the N-terminal death domain binds the death domain-containing protein kinases, such as the IL-1R-associated kinase 4 (IRAK4), which phosphorylate another kinase, IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m66*0.1
nodelay
--
0
PMID: 17576036 The latter binds to and phosphorylates TRAF6, a ubiquitin ligase that targets TGF-activated kinase (TAK)1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m68*m183*0.1
nodelay
--
0
PMID: 17576036 The latter binds to and phosphorylates TRAF6, a ubiquitin ligase that targets TGF-activated kinase (TAK)1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c12 : 1
m15*0.1
nodelay
--
0
PMID: 17576036, 8455596, 2884660, 2038339 Depending on promoter organization, simple GREs could confer either activation (sgk1; tyrosine hydroxylase; chromogranin A) or repression of transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m69*0.1
nodelay
--
0
PMID: 17576036 The latter binds to and phosphorylates TRAF6, a ubiquitin ligase that targets TGF-activated kinase (TAK)1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m70*m1573*0.1
nodelay
--
0
PMID: 17576036 The latter binds to and phosphorylates TRAF6, a ubiquitin ligase that targets TGF-activated kinase (TAK)1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m71*0.1
nodelay
--
0
PMID: 17576036 The latter binds to and phosphorylates TRAF6, a ubiquitin ligase that targets TGF-activated kinase (TAK)1.
p43
p43
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m72*m207*0.1
nodelay
--
0
PMID: 17576036, 16186825, 16260493 Activated TAK1 in turn initiates a cascade of phosphorylation events ultimately inducing the IkappaB kinase (IKK) and the MKK3,4,6/JNK/p38 pathways.
p44
p44
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m72*m1875*0.1
nodelay
--
0
PMID: 17576036, 16186825, 16260493 Activated TAK1 in turn initiates a cascade of phosphorylation events ultimately inducing the IkappaB kinase (IKK) and the MKK3,4,6/JNK/p38 pathways.
p45
p45
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c130 : 1
stoichiometry:c129 : 1
m1832*m74*0.1
nodelay
--
0
PMID: 17576036, 16186825, 16260493 Activated TAK1 in turn initiates a cascade of phosphorylation events ultimately inducing the IkappaB kinase (IKK) and the MKK3,4,6/JNK/p38 pathways.
p46
p46
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c131 : 1
stoichiometry:c133 : 1
m3613*m16555*0.1
nodelay
--
0
PMID: 17576036, 16186825, 16260493 Activated TAK1 in turn initiates a cascade of phosphorylation events ultimately inducing the IkappaB kinase (IKK) and the MKK3,4,6/JNK/p38 pathways.
p47
p47
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c134 : 1
stoichiometry:c184 : 1
stoichiometry:c136 : 1
m75*m16567*0.1
nodelay
--
0
PMID: 17576036, 16186825, 16260493 Activated TAK1 in turn initiates a cascade of phosphorylation events ultimately inducing the IkappaB kinase (IKK) and the MKK3,4,6/JNK/p38 pathways. PMID: 17576036, 9407028, 9794429 glucocorticoids inhibit several TLR-activated protein kinases including JNK and p38 without altering their levels, suggesting that GR does not repress transcription of JNK or p38.
p48
p48
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c137 : 1
stoichiometry:c185 : 1
stoichiometry:c139 : 1
m77*m16567*0.1
nodelay
--
0
PMID: 17576036, 16186825, 16260493 Activated TAK1 in turn initiates a cascade of phosphorylation events ultimately inducing the IkappaB kinase (IKK) and the MKK3,4,6/JNK/p38 pathways. PMID: 17576036, 9407028, 9794429 glucocorticoids inhibit several TLR-activated protein kinases including JNK and p38 without altering their levels, suggesting that GR does not repress transcription of JNK or p38.
p49
p49
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c142 : 1
stoichiometry:c141 : 1
m186*m73*0.1
nodelay
--
0
PMID: 17576036 The former activates transcription factor NFkappaB through the phosphorylation and degradation of its inhibitor, IkappaB, while the latter is involved in numerous stress-related pathways including activation of transcription factors from the AP1 family.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c13 : 1
m15*0.1
nodelay
--
0
PMID: 17576036, 8455596, 2884660, 2038339 Depending on promoter organization, simple GREs could confer either activation (sgk1; tyrosine hydroxylase; chromogranin A) or repression of transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
stoichiometry:c145 : 1
m79*0.1
nodelay
--
0
PMID: 17576036 The former activates transcription factor NFkappaB through the phosphorylation and degradation of its inhibitor, IkappaB, while the latter is involved in numerous stress-related pathways including activation of transcription factors from the AP1 family.
p51
p51
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c146 : 1
stoichiometry:c148 : 1
m219*m78*0.1
nodelay
--
0
PMID: 17576036 The former activates transcription factor NFkappaB through the phosphorylation and degradation of its inhibitor, IkappaB, while the latter is involved in numerous stress-related pathways including activation of transcription factors from the AP1 family.
p52
p52
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 17576036, 16720699 In TLR3, two positively charged patches (patch1 and patch2) were proposed to be involved in interaction with dsRNA as substitution of either of these patches with alanines abolishes TLR3 signaling.
p53
p53
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c55 : 1
stoichiometry:c153 : 1
m18998*m19314*0.1
nodelay
--
0
PMID: 17576036, 12471095 TLR3 is the only TLR which does not interact with MyD88 and utilizes another TIR-domain adaptor, TRIF.
p54
p54
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m83*m1599*m3902*m977*0.1
nodelay
--
0
PMID: 17576036, 16822173, 12692549 The N-terminal domain of TRIF interacts with IRF3 and several kinases including IKK-related TBK1 and IKKepsilon.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c309 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m84*m67*0.1
nodelay
--
0
PMID: 17576036 TBK1/IKKepsilon phosphorylate IRF3 and possibly IRF7 leading to dimerization and nuclear translocation of these transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m85*0.1
nodelay
--
0
PMID: 17576036 TBK1/IKKepsilon phosphorylate IRF3 and possibly IRF7 leading to dimerization and nuclear translocation of these transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
m87*0.1
nodelay
--
0
PMID: 17576036 TBK1/IKKepsilon phosphorylate IRF3 and possibly IRF7 leading to dimerization and nuclear translocation of these transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m89*m83*0.1
nodelay
--
0
PMID: 17576036 The C-terminal domain of TRIF interacts with protein kinase RIP1.
p59
p59
cso30:i:ME_Dephosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c182 : 1
stoichiometry:c176 : 1
m76*m91*0.1
nodelay
--
0
PMID: 17576036, 17073741 Negative regulation of these pathways involves dephosphorylation of JNK, p38 and their upstream kinases MEK3,4,6 by MAPK phosphatases (MKPs, also known as DUSPs).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c14 : 1
m15*0.1
nodelay
--
0
PMID: 17576036, 8455596, 2884660, 2038339 Depending on promoter organization, simple GREs could confer either activation (sgk1; tyrosine hydroxylase; chromogranin A) or repression of transcription.
p60
p60
cso30:i:ME_Dephosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c181 : 1
stoichiometry:c174 : 1
m16567*m91*0.1
nodelay
--
0
PMID: 17576036, 17073741 Negative regulation of these pathways involves dephosphorylation of JNK, p38 and their upstream kinases MEK3,4,6 by MAPK phosphatases (MKPs, also known as DUSPs).
p61
p61
cso30:i:ME_Dephosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c180 : 1
stoichiometry:c172 : 1
m16555*m91*0.1
nodelay
--
0
PMID: 17576036, 17073741 Negative regulation of these pathways involves dephosphorylation of JNK, p38 and their upstream kinases MEK3,4,6 by MAPK phosphatases (MKPs, also known as DUSPs).
p62
p62
cso30:i:ME_Dephosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c179 : 1
stoichiometry:c170 : 1
m74*m91*0.1
nodelay
--
0
PMID: 17576036, 17073741 Negative regulation of these pathways involves dephosphorylation of JNK, p38 and their upstream kinases MEK3,4,6 by MAPK phosphatases (MKPs, also known as DUSPs).
p63
p63
cso30:i:ME_Dephosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c183 : 1
stoichiometry:c178 : 1
m78*m91*0.1
nodelay
--
0
PMID: 17576036, 17073741 Negative regulation of these pathways involves dephosphorylation of JNK, p38 and their upstream kinases MEK3,4,6 by MAPK phosphatases (MKPs, also known as DUSPs).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c193 : 1
stoichiometry:c194 : 1
m2002*m94*0.1
nodelay
--
0
PMID: 17576036, 15032587 These proteins contain SH2 domains which physically interact with JAKs competitively blocking their interaction with STATs as well as serve as adapters for E3 ubiquitin ligases which target JAKs for degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c196 : 1
stoichiometry:c198 : 1
stoichiometry:c197 : 1
m94*m96*0.1
nodelay
--
0
PMID: 17576036, 15032587 These proteins contain SH2 domains which physically interact with JAKs competitively blocking their interaction with STATs as well as serve as adapters for E3 ubiquitin ligases which target JAKs for degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c187 : 1
m93*0.1
nodelay
--
0
PMID: 17576036, 16415872 Recently, SOCS1 was reported to also directly interfere with TLR 2 and 4 signaling by inducing rapid degradation of their TIR domain-containing adaptor TIRAP through ubiquitin-mediated proteolysis.
p67
p67
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m6810*m1906*0.1
nodelay
--
0
PMID: 17576036, 16415872 Recently, SOCS1 was reported to also directly interfere with TLR 2 and 4 signaling by inducing rapid degradation of their TIR domain-containing adaptor TIRAP through ubiquitin-mediated proteolysis.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c205 : 1
m13*0.1
nodelay
--
0
PMID: 17576036, 11259387, 12054511, 16293608 Interestingly, SOCS1 mRNA is induced by glucocorticoids in several cell lines of hematopoietic origin and in acute lymphoblastic leukemia (ALL) patients.
p69
p69
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c204 : 1
stoichiometry:c200 : 1
stoichiometry:c201 : 1
m95*m227*0.1
nodelay
--
0
PMID: 17576036, 15032587 These proteins contain SH2 domains which physically interact with JAKs competitively blocking their interaction with STATs as well as serve as adapters for E3 ubiquitin ligases which target JAKs for degradation.
p7
p7
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c17 : 1
stoichiometry:c20 : 1
m93229*0.1
nodelay
--
0
PMID: 17576036, 8455596, 2884660, 2038339 Depending on promoter organization, simple GREs could confer either activation (sgk1; tyrosine hydroxylase; chromogranin A) or repression of transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
m98*0.1
nodelay
--
0
PMID: 17576036, 15032587 These proteins contain SH2 domains which physically interact with JAKs competitively blocking their interaction with STATs as well as serve as adapters for E3 ubiquitin ligases which target JAKs for degradation.
p71
p71
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c208 : 1
stoichiometry:c235 : 1
stoichiometry:c207 : 1
m49*m16*0.1
nodelay
--
0
PMID: 17576036, 11468175, 9430225, 17208592 Glucocorticoid-inducible leucine zipper (GILZ) is a small protein with a wide spectrum of anti-inflammatory activities including inhibition of LPS-induced expression of TLR2 in macrophages and of TLR 2- and 3-mediated NFkappaB activation in airway epithelial cells; inhibition of dendritic cells¡Ç maturation, and enhancement of spontaneous thymocyte apoptosis, likely through downregulation of the anti-apoptotic factor Bcl-X. PMID: 17576036, 11028557, 11160251, 11867630 Transcription of the TLR2 gene in response to TLR agonists is activated by NFkappaB and could therefore be expected to be glucocorticoid-sensitive. PMID: 17576036 In HeLa cervical carcinoma cells, the basal TLR2 expression is low but is induced upon exposure to lipoprotein from the Gram-negative bacterium Haemophilus influenzae and further potentiated by glucocorticoids. PMID: 17576036,16765091 in dendritic cells, glucocorticoids augment the expression of both TLR2 and TLR4, but inhibit the production of proinflammatory cytokines TNF-alpha and IL-12 in response to TLR agonists, suggesting that TLR2 signaling is blocked downstream of the receptor and that a mere increase in the amount of TLR2 does not relieve this block.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c209 : 1
stoichiometry:c210 : 1
1.0*0.1
nodelay
--
0
PMID: 17576036, 11468175, 9430225, 17208592 Glucocorticoid-inducible leucine zipper (GILZ) is a small protein with a wide spectrum of anti-inflammatory activities including inhibition of LPS-induced expression of TLR2 in macrophages and of TLR 2- and 3-mediated NFkappaB activation in airway epithelial cells; inhibition of dendritic cells¡Ç maturation, and enhancement of spontaneous thymocyte apoptosis, likely through downregulation of the anti-apoptotic factor Bcl-X.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c211 : 1
stoichiometry:c213 : 1
stoichiometry:c212 : 1
m107*m81*0.1
nodelay
--
0
PMID: 17576036, 11468175, 11397794 GILZ was reported to physically interact with several effectors of TLR signaling, most notably Fos, Jun and p65/RelA. PMID: 17576036, 17169985, 11397794, 12391160 Interestingly, GILZ homodimerization through the leucine zipper domain is required for its interaction with NFkappaB, but not AP1 or Raf-1, suggesting that GILZ interaction surfaces are partner-specific.
p74
p74
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c216 : 1
m101*0.1
nodelay
--
0
PMID: 17576036, 12391160 In addition, GILZ binds to the protein kinase Raf-1 blocking its phosphorylation and, consequently, activation of downstream MAPKs, Erk 1 and 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c217 : 1
stoichiometry:c218 : 1
m5*m101*0.1
nodelay
--
0
PMID: 17576036, 12391160 In addition, GILZ binds to the protein kinase Raf-1 blocking its phosphorylation and, consequently, activation of downstream MAPKs, Erk 1 and 2.
p76
p76
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c219 : 1
stoichiometry:c222 : 1
stoichiometry:c283 : 1
stoichiometry:c223 : 1
m16621*m549*0.1
nodelay
--
0
PMID: 17576036, 12391160 In addition, GILZ binds to the protein kinase Raf-1 blocking its phosphorylation and, consequently, activation of downstream MAPKs, Erk 1 and 2.
p77
p77
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c224 : 1
stoichiometry:c316 : 1
stoichiometry:c221 : 1
m554*m103*0.1
nodelay
--
0
PMID: 17576036, 12391160 In addition, GILZ binds to the protein kinase Raf-1 blocking its phosphorylation and, consequently, activation of downstream MAPKs, Erk 1 and 2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c225 : 1
stoichiometry:c229 : 1
stoichiometry:c227 : 1
m5*m221*0.1
nodelay
--
0
PMID: 17576036, 11468175, 11397794 GILZ was reported to physically interact with several effectors of TLR signaling, most notably Fos, Jun and p65/RelA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c230 : 1
stoichiometry:c228 : 1
m5*m106*0.1
nodelay
--
0
PMID: 17576036, 11468175, 11397794 GILZ was reported to physically interact with several effectors of TLR signaling, most notably Fos, Jun and p65/RelA.
p8
p8
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m93252*0.1
nodelay
--
0
PMID: 17576036, 8455596, 2884660, 2038339 Depending on promoter organization, simple GREs could confer either activation (sgk1; tyrosine hydroxylase; chromogranin A) or repression of transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c231 : 1
stoichiometry:c232 : 1
m5*0.1
nodelay
--
0
PMID: 17576036, 17169985, 11397794, 12391160 Interestingly, GILZ homodimerization through the leucine zipper domain is required for its interaction with NFkappaB, but not AP1 or Raf-1, suggesting that GILZ interaction surfaces are partner-specific.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c234 : 1
m13*0.1
nodelay
--
0
PMID: 17576036, 11259387, 9430225, 12393603 GILZ is dramatically induced by glucocorticoids in a wide range of cell types, and this induction requires the GR dimer interface and DNA binding, suggesting that GILZ is a direct transcriptional target for the receptor.
p82
p82
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c237 : 1
stoichiometry:c238 : 1
m3964*m109*0.1
nodelay
--
0
PMID: 17576036, 12356755 ectopic overexpression of TLR2 in HeLa cells indeed results in elevated transcription of TNF-alpha, IL-8 and IL-1¦Â in response to TLR2 agonists.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c239 : 1
stoichiometry:c240 : 1
m93848*0.1
nodelay
--
0
PMID: 17576036, 12356755 ectopic overexpression of TLR2 in HeLa cells indeed results in elevated transcription of TNF-alpha, IL-8 and IL-1¦Â in response to TLR2 agonists.
p84
p84
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c255 : 1
stoichiometry:c244 : 1
m110*0.1
nodelay
--
0
PMID: 17576036, 12356755 ectopic overexpression of TLR2 in HeLa cells indeed results in elevated transcription of TNF-alpha, IL-8 and IL-1beta in response to TLR2 agonists. PMID: 17576036,16765091 in dendritic cells, glucocorticoids augment the expression of both TLR2 and TLR4, but inhibit the production of proinflammatory cytokines TNF-alpha and IL-12 in response to TLR agonists, suggesting that TLR2 signaling is blocked downstream of the receptor and that a mere increase in the amount of TLR2 does not relieve this block.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c243 : 1
stoichiometry:c245 : 1
m110*0.1
nodelay
--
0
PMID: 17576036, 12356755 ectopic overexpression of TLR2 in HeLa cells indeed results in elevated transcription of TNF-alpha, IL-8 and IL-1¦Â in response to TLR2 agonists.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c242 : 1
stoichiometry:c246 : 1
m110*0.1
nodelay
--
0
PMID: 17576036, 12356755 ectopic overexpression of TLR2 in HeLa cells indeed results in elevated transcription of TNF-alpha, IL-8 and IL-1¦Â in response to TLR2 agonists.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c248 : 1
m110*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c249 : 1
stoichiometry:c250 : 1
m110*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c252 : 1
stoichiometry:c251 : 1
1.0*0.1
nodelay
--
0
PMID: 17576036,16765091 in dendritic cells, glucocorticoids augment the expression of both TLR2 and TLR4, but inhibit the production of proinflammatory cytokines TNF-alpha and IL-12 in response to TLR agonists, suggesting that TLR2 signaling is blocked downstream of the receptor and that a mere increase in the amount of TLR2 does not relieve this block.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m13*m16*0.1
nodelay
--
0
PMID: 17576036, 2169352, 10995388, 9388192 Tethering GREs do not contain bona fide DNA recognition sequence for GR, but rather a binding site for another transcription factor which recruits GR through protein:protein interactions. Binding to tethering GREs often requires neither GR DNA binding activity nor its dimerization. Several transcription factors, including AP1, NFkappaB, Stat3 and Stat5 can provide a ¡Ètether¡É for GR.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c253 : 1
stoichiometry:c254 : 1
m13*0.1
nodelay
--
0
PMID: 17576036,16765091 in dendritic cells, glucocorticoids augment the expression of both TLR2 and TLR4, but inhibit the production of proinflammatory cytokines TNF-alpha and IL-12 in response to TLR agonists, suggesting that TLR2 signaling is blocked downstream of the receptor and that a mere increase in the amount of TLR2 does not relieve this block.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c259 : 1
stoichiometry:c263 : 1
stoichiometry:c265 : 1
m110*m113*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
p92
p92
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c258 : 1
stoichiometry:c264 : 1
stoichiometry:c266 : 1
m110*m113*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
p93
p93
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c257 : 1
stoichiometry:c274 : 1
stoichiometry:c267 : 1
m110*m115*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
p94
p94
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c260 : 1
stoichiometry:c261 : 1
stoichiometry:c262 : 1
m112*m230*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c272 : 1
stoichiometry:c273 : 1
stoichiometry:c268 : 1
m115*m110*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
p96
p96
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c269 : 1
stoichiometry:c270 : 1
stoichiometry:c271 : 1
m114*m1639*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
p97
p97
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c277 : 1
stoichiometry:c280 : 1
stoichiometry:c275 : 1
m110*m13*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c278 : 1
stoichiometry:c279 : 1
stoichiometry:c276 : 1
m110*m13*0.1
nodelay
--
0
PMID: 17576036, 15242847 Similarly, in the A549 lung epithelial cell line, the induction of IL-6 and IL-8 by TLR2 agonist peptidoglycan is enhanced by co-treatment with TNF-alpha, IFNgamma and glucocorticoid.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c281 : 1
stoichiometry:c282 : 1
m122*0.1
nodelay
--
0
PMID: 17576036 Several IRFs, including IRF1, 2, 3, 5 and 7 interact with CBP/p300 coactivators through the C-terminal IAD domain.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--